BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 15804465)

  • 41. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
    Catteau X; Simon P; Noël JC
    Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
    Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical applications of sentinel lymph node biopsy in ductal carcinoma in situ of the breast: a dilemma.
    Tang Y; Xu F; Tao K; Qian N; Toi M
    Tohoku J Exp Med; 2011 May; 224(1):1-5. PubMed ID: 21502730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
    Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
    Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
    Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
    J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
    Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
    Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ.
    Hung WK; Ying M; Chan M; Mak KL; Chan LK
    Breast Cancer; 2010 Oct; 17(4):276-80. PubMed ID: 19756924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
    Pilewskie M; Karsten M; Radosa J; Eaton A; King TA
    Ann Surg Oncol; 2016 Jul; 23(7):2229-34. PubMed ID: 26960927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
    van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
    Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
    Kurniawan ED; Rose A; Mou A; Buchanan M; Collins JP; Wong MH; Miller JA; Mann GB
    Arch Surg; 2010 Nov; 145(11):1098-104. PubMed ID: 21079099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of primary breast cancer characteristics in predicting positive sentinel lymph node biopsy results: a multivariate analysis.
    Chen M; Palleschi S; Khoynezhad A; Gecelter G; Marini CP; Simms HH
    Arch Surg; 2002 May; 137(5):606-9; discussion 609-10. PubMed ID: 11982477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.
    Hotton J; Salleron J; Rauch P; Buhler J; Pierret M; Baumard F; Leufflen L; Marchal F
    J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101641. PubMed ID: 31562936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
    Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
    Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.